Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Fusion Pharmaceuticals Q4 EPS $(0.40) Down From $(0.32) YoY

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.40) per share. This is a 25 percent decrease over losses of $(0.32) per share from the same period last year.

byBenzinga Newsdesk

March 17, 2022

1 minute read

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.40) per share. This is a 25 percent decrease over losses of $(0.32) per share from the same period last year.

EF Hutton Assumes Superior Drilling Prods at Buy, Announces Price Target of $2

By Benzinga Newsdesk

Today, 6:22 AM

EF Hutton analyst Ignacio Bernaldez assumes Superior Drilling Prods (AMEX:SDPI) with a Buy rating and announces Price Target of $2.

SDPI

Tremor Intl Q3 Adj. EPS $0.11 Misses $0.24 Estimate, Sales $70.85M Miss $75.26M Estimate

By Benzinga Newsdesk

Today, 6:22 AM

Tremor Intl (NASDAQ:TRMR) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.24 by 54.17 percent. This is a 47.62 percent decrease over earnings of $0.21 per share from the

TRMR